Israel Medical Cannabis Market to 2032
Overview
The Israel Medical Cannabis Market is expected to reach a 615.43 USD Billion by 2032 and is projected to grow at a CAGR of 35.58% from 2025 to 2032.
Revenue, 2024 (USD Billion)
126.76
Forecast, 2032 (USD Billion)
615.43
CAGR, 2024 - 2032
35.58%
Report Coverage
Israel
Israel Medical Cannabis Market 2018-2032 USD Billion
Israel Medical Cannabis Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 126.76 USD Billion
- Projected Market Size (2032): 615.43 USD Billion
- CAGR (2025-2032): 35.58%
Key Findings of Israel Medical Cannabis Market
- The Israel Medical Cannabis Market was valued at 126.76 USD Billion in 2024.
- The Israel Medical Cannabis Market is likely to grow at a CAGR of 35.58% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Sativa in Species Segment accounted for the largest share of the market with a revenue of 78.84 USD Billion
- The fastest growing segment Pain Management in Application Segment grew Fastest with a CAGR of 43.16% during the forecast period from 2024 to 2032.
Israel Medical Cannabis Market Scope
Israel Medical Cannabis Market Segmentation & Scope
Distribution Channel
- B2B
- B2C
End User
- Others
- Research And Development Centers
- Pharmaceutical Industry
- Rehab Centers
- Hospital
- Homecare Setting
Application
- Elevate Mood
- Mental Health Conditions
- Autism
- Multiple Sclerosis
- Depression And Sleep Disorders
- Epilepsy
- Alzheimer'S Disease/Migranes
- Arthritis
- Cancer
- Others
- Appetite Loss
- Nausea
- Muscle Spasms
- Anxiety
- Pain Management
Route of Administration
- Others
- Vaporizers
- Topicals
- Smoking
- Oral Solutions And Capsules
Product
- Cleanser
- Masks & Serum
- Patch
- Ground Flower
- Creams & Moisturizer
- Whole Flower
- Vape Pen
- Others
- Medical Cannabis Capsules
- Dried Medical Cannabis
- Oil
Source
- Synthetic
- Natural
Species
- Cannabis Indica
- Hybrid
- Sativa
Derivatives
- Cannabinol (CBN)
- Others
- Cannabigerol (CBG)
- Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
- Cannabidiol (CBD)
Israel Medical Cannabis Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 126.76 USD Billion |
| Market Value in 2032 | 615.43 USD Billion |
| CAGR (2025-2032) | 35.58% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Application,Route of Administration,Product,Source,Species,Derivatives |
Regional Insights:
-
Leading Market (2024-2032): Israel, leading in terms of revenue 126.76 USD Billion in 2024
- Key Country: Israel, leading in terms of revenue with value of 126.76 USD Billion in 2024.
Segments and Scope
-
Israel Medical Cannabis Market to 2032, By Distribution Channel
- B2C is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 76.04 USD Billion in the year 2024.
- B2C is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 37.49 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By End User
- Homecare Setting is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 40.54 USD Billion in the year 2024.
- Rehab Centers is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 36.50 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By Application
- Pain Management is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 28.56 USD Billion in the year 2024.
- Pain Management is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 43.16 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By Route of Administration
- Oral Solutions And Capsules is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 67.63 USD Billion in the year 2024.
- Smoking is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 36.93 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By Product
- Oil is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 37.21 USD Billion in the year 2024.
- Oil is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 42.05 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By Source
- Natural is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 73.53 USD Billion in the year 2024.
- Natural is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 37.65 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By Species
- Sativa is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 78.84 USD Billion in the year 2024.
- Sativa is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 37.10 % in forecast period 2025-2032.
-
Israel Medical Cannabis Market to 2032, By Derivatives
- Cannabidiol (CBD) is the largest segment in Israel Medical Cannabis Market to 2032 with a revenue of 75.48 USD Billion in the year 2024.
- Cannabidiol (CBD) is the Fastest growing segment in Israel Medical Cannabis Market to 2032 with a Growth rate of 37.54 % in forecast period 2025-2032.
Israel Medical Cannabis Market Company Share Analysis
| Company Name |
|
||
| Medipharm Labs | |||
| Tilray | |||
| Zenabis Global Ltd. | |||
| Canopy Growth Corporation | |||
| Aurora Cannabis | |||
Israel Medical Cannabis Market Geographical Sales Distribution, 2018-2032 USD Billion
Israel Medical Cannabis Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Israel Medical Cannabis Market is segmented based on Segmentation Distribution Channel,End User,Application,Route of Administration,Product,Source,Species,Derivatives.
Israel Medical Cannabis Market was valued at USD 126.76(Revenue in USD Billion) in 2020.
Israel Medical Cannabis Market is projected to grow at a CAGR of 35.58% during the forecast period of 2024 to 2032.
The Sativa segment is expected to dominate the Israel Medical Cannabis Market, holding a largest market share of 78.84 USD Billion in 2024
Israel Medical Cannabis Market Scope
Israel Medical Cannabis Market Segmentation & Scope
Distribution Channel
- B2B
- B2C
End User
- Others
- Research And Development Centers
- Pharmaceutical Industry
- Rehab Centers
- Hospital
- Homecare Setting
Application
- Elevate Mood
- Mental Health Conditions
- Autism
- Multiple Sclerosis
- Depression And Sleep Disorders
- Epilepsy
- Alzheimer'S Disease/Migranes
- Arthritis
- Cancer
- Others
- Appetite Loss
- Nausea
- Muscle Spasms
- Anxiety
- Pain Management
Route of Administration
- Others
- Vaporizers
- Topicals
- Smoking
- Oral Solutions And Capsules
Product
- Cleanser
- Masks & Serum
- Patch
- Ground Flower
- Creams & Moisturizer
- Whole Flower
- Vape Pen
- Others
- Medical Cannabis Capsules
- Dried Medical Cannabis
- Oil
Source
- Synthetic
- Natural
Species
- Cannabis Indica
- Hybrid
- Sativa
Derivatives
- Cannabinol (CBN)
- Others
- Cannabigerol (CBG)
- Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
- Cannabidiol (CBD)
Frequently Asked Questions
The Israel Medical Cannabis Market is segmented based on Segmentation Distribution Channel,End User,Application,Route of Administration,Product,Source,Species,Derivatives.
Israel Medical Cannabis Market was valued at USD 126.76(Revenue in USD Billion) in 2020.
Israel Medical Cannabis Market is projected to grow at a CAGR of 35.58% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Medical Cannabis Market for final year is USD 615.43 (USD Billion).
Israel Medical Cannabis Market Company Profiling
Frequently Asked Questions
The Israel Medical Cannabis Market is segmented based on Segmentation Distribution Channel,End User,Application,Route of Administration,Product,Source,Species,Derivatives.
Israel Medical Cannabis Market was valued at USD 126.76(Revenue in USD Billion) in 2020.
Israel Medical Cannabis Market is projected to grow at a CAGR of 35.58% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Medical Cannabis Market for final year is USD 615.43 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.